speb/financial-data huggingface dataset:
HCG.NS income_statement (annual, 2023-03-31) — EBIT: 1392750000.00
HCG.NS income_statement (annual, 2023-03-31) — EBITDA: 3027480000.00
HCG.NS cash_flow (annual, 2023-03-31) — End Cash Position: 1711820000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 68380000.00
HCG.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -1400670000.00
HCG.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 1183540000.00
HCG.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -350000.00
HCG.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 13220000.00
HCG.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 674290000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Goodwill: 1812340000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1999340000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 3500410000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 21718290000.00
HCG.NS income_statement (annual, 2023-03-31) — Gross Profit: 8762920000.00
HCG.NS income_statement (annual, 2023-03-31) — Interest Expense: 943950000.00
HCG.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 943950000.00
HCG.NS income_statement (annual, 2023-03-31) — Interest Income: 118100000.00
HCG.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 118100000.00
HCG.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -956110000.00
HCG.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 65720000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Inventory: 382860000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 12598570000.00
HCG.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1330320000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 198110000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 28510000.00
HCG.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 8860000.00
HCG.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 554340000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 647230000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 4530610000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 3617410000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 8148020000.00
HCG.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 554340000.00
HCG.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -627560000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 28510000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 131900000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 11213190000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 88940000.00
HCG.NS income_statement (annual, 2023-03-31) — Minority Interests: 117190000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 8860000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2247160000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 17560000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Income: 293490000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 293490000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 176300000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 293490000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 293490000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 448800000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 176300000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Interest Income: -895900000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -132160000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -73220000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -73220000.00
HCG.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -895900000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 9000000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 12900000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Net PPE: 13712721000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1256780000.00
HCG.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 0.00
HCG.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 6605880000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 359270000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 52740000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 123660000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 131860000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 828890000.00
HCG.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 3353600000.00
HCG.NS income_statement (annual, 2023-03-31) — Normalized Income: 521774000.00
HCG.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 2515910000.00
HCG.NS income_statement (annual, 2023-03-31) — Operating Income: 1682500000.00
HCG.NS income_statement (annual, 2023-03-31) — Operating Revenue: 16760470000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 139975908.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 339200000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 755100000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 120280000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 187000000.00
HCG.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 830220000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -251000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 359300000.00
HCG.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 6060000.00
HCG.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1756110000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Payable: 198710000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Properties: 533600000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 14850000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 292300000.00
HCG.NS income_statement (annual, 2023-03-31) — Other Special Charges: 9350000.00
HCG.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS balance_sheet (annual, 2023-03-31) — Payables: 2707930000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 171140000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 360290000.00
HCG.NS income_statement (annual, 2023-03-31) — Pretax Income: 448800000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
HCG.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -124880000.00
HCG.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
HCG.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -634080000.00
HCG.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1332370000.00
HCG.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 7997550000.00
HCG.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1634730000.00
HCG.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 111550000.00
HCG.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 111550000.00
HCG.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -627560000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 220200000.00
HCG.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
HCG.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -4522450000.00
HCG.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
HCG.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 501920000.00
HCG.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 75590000.00
HCG.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 336500000.00
HCG.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1010790000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Share Issued: 139975908.00
HCG.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 0.00
HCG.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: 0.00
HCG.NS income_statement (annual, 2023-03-31) — Special Income Charges: -326470000.00
HCG.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 65140000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 8605220000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 6605880000.00
HCG.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -97836000.00
HCG.NS income_statement (annual, 2023-03-31) — Tax Provision: 272500000.00
HCG.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
HCG.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 53850000.00
HCG.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -227150000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Assets: 23160170000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 12222630000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Debt: 9011980000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 8694160000.00
HCG.NS income_statement (annual, 2023-03-31) — Total Expenses: 15077970000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 14466010000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 17356820000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 8762810000.00
HCG.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 70050000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 24680000.00
HCG.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -326120000.00
HCG.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -326120000.00
HCG.NS balance_sheet (annual, 2023-03-31) — Working Capital: 100150000.00
HCG.NS income_statement (annual, 2023-03-31) — Write Off: 317120000.00
HCG.NS income_statement (annual, 2024-03-31) — +Operating Expense: 8224830000.00
HCG.NS income_statement (annual, 2024-03-31) — +Total Revenue: 18899080000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2810650000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2940260000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -9500050000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 11688730000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -700910000.00
HCG.NS income_statement (annual, 2024-03-31) — Amortization: 77250000.00
HCG.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 77250000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 86580000.00
HCG.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 140097725.00
HCG.NS income_statement (annual, 2024-03-31) — Basic EPS: 3.44
HCG.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1711820000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 11252640000.00
HCG.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -1856800000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 6016030000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 1392900000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 2726130000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 2726130000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 2136740000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 589390000.00
HCG.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -39510000.00
HCG.NS cash_flow (annual, 2024-03-31) — Change In Payable: 99380000.00
HCG.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -357370000.00
HCG.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -271880000.00
HCG.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -51640000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Common Stock: 1392900000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 8257800000.00
HCG.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 19490000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 831840000.00
HCG.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 9099890000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Assets: 6798520000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 427870000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1874560000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 2302430000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 155840000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 7437050000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 182800000.00
HCG.NS cash_flow (annual, 2024-03-31) — Depreciation: 1666310000.00
HCG.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1743560000.00
HCG.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1743560000.00
HCG.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1666310000.00
HCG.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 141274157.00
HCG.NS income_statement (annual, 2024-03-31) — Diluted EPS: 3.41
HCG.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 481550000.00
HCG.NS income_statement (annual, 2024-03-31) — EBIT: 1684230000.00
HCG.NS income_statement (annual, 2024-03-31) — EBITDA: 3427790000.00
HCG.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1660180000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 69650000.00
HCG.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -640160000.00
HCG.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 988990000.00
HCG.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -2170000.00
HCG.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 17740000.00
HCG.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 678710000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Goodwill: 2229350000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2696270000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3641170000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 25217470000.00
HCG.NS income_statement (annual, 2024-03-31) — Gross Profit: 9799190000.00
HCG.NS income_statement (annual, 2024-03-31) — Interest Expense: 1006940000.00
HCG.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1006940000.00
HCG.NS income_statement (annual, 2024-03-31) — Interest Income: 126970000.00
HCG.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 126970000.00
HCG.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1170950000.00
HCG.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 82070000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Inventory: 426680000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 14985370000.00
HCG.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2257270000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 156230000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 33600000.00
HCG.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 19490000.00
HCG.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 2900170000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 647230000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 5588160000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 4853010000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 10441170000.00
HCG.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 2900170000.00
HCG.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1511400000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 33600000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 156600000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 11812260000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 393380000.00
HCG.NS income_statement (annual, 2024-03-31) — Minority Interests: 68210000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -450000000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 19490000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Net Debt: 4001440000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -650000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Income: 481550000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 481550000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 413340000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 481550000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 481550000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 677290000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 413340000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Interest Income: -956580000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -14300000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 1388770000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 1388770000.00
HCG.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -956580000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -422000000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -35250000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Net PPE: 15717420000.00
HCG.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1839790000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 5561530000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 328210000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 70580000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 60750000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 156620000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 832910000.00
HCG.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 3391060000.00
HCG.NS income_statement (annual, 2024-03-31) — Normalized Income: 459134228.03
HCG.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2845790000.00
HCG.NS income_statement (annual, 2024-03-31) — Operating Income: 1574360000.00
HCG.NS income_statement (annual, 2024-03-31) — Operating Revenue: 18899080000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 140150606.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 313600000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 39760000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 175550000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 466920000.00
HCG.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 838640000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -240000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 328200000.00
HCG.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 18250000.00
HCG.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2322610000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Payable: 244000000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Properties: 673500000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 6990000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 372400000.00
HCG.NS income_statement (annual, 2024-03-31) — Other Special Charges: -38880000.00
HCG.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS balance_sheet (annual, 2024-03-31) — Payables: 3076630000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 182860000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 338110000.00
HCG.NS income_statement (annual, 2024-03-31) — Pretax Income: 677290000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
HCG.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 238040000.00
HCG.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -450000000.00
HCG.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -265700000.00
HCG.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1856800000.00
HCG.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 9099890000.00
HCG.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1743560000.00
HCG.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 218400000.00
HCG.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 218400000.00
HCG.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1511400000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 304600000.00
HCG.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 0.00
HCG.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -4962480000.00
HCG.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 251400000.00
HCG.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 17010000.00
HCG.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 401240000.00
HCG.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1079950000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Share Issued: 140150606.00
HCG.NS income_statement (annual, 2024-03-31) — Special Income Charges: 34560000.00
HCG.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 78460000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 8257800000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 5561530000.00
HCG.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 14314228.03
HCG.NS income_statement (annual, 2024-03-31) — Tax Provision: 263950000.00
HCG.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.39
HCG.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 55750000.00
HCG.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -473680000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Assets: 27074980000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 13110810000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Debt: 12743600000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 8651180000.00
HCG.NS income_statement (annual, 2024-03-31) — Total Expenses: 17324720000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 18423800000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 20276460000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 10986750000.00
HCG.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 76610000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 21980000.00
HCG.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 36730000.00
HCG.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 36730000.00
HCG.NS balance_sheet (annual, 2024-03-31) — Working Capital: -638530000.00
HCG.NS income_statement (annual, 2024-03-31) — Write Off: 4320000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 3252700000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3560200000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 639800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 8080600000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 1393900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2782100000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2960600000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 1393900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 8617900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 356500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 7529300000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 464900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 2394700000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 2859600000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 8354300000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 191000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 2230200000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2518900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 18749000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 495900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 16116800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 639800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 7615700000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 5104200000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 12719900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 40100000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 157800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 437600000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 4716800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 18749000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 6099000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 79500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 5800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 140248251.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 488400000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 401900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 7224000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 288700000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 414400000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 377500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 18392500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 24200000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 178500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Payables: 3282700000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 140248251.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 8617900000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 6099000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 30670800000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 13722100000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 15579500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 9055500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 21615300000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 23141500000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 13261000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 30000000.00
HCG.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -825000000.00
HCG.NS income_statement (annual, 2025-03-31) — +Operating Expense: 9799300000.00
HCG.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 2525500000.00
HCG.NS income_statement (annual, 2025-03-31) — +Total Revenue: 22181400000.00
HCG.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 5834300000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 3342590000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3342590000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 4008960000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 4008960000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -10887080000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -10887080000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 11719840000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 11719840000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -807880000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -807880000.00
HCG.NS income_statement (annual, 2025-03-31) — Amortization: 128640000.00
HCG.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 128640000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 207890000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 207890000.00
HCG.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 140094637.00
HCG.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 141538462.00
HCG.NS income_statement (annual, 2025-03-31) — Basic EPS: 3.17
HCG.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.52
HCG.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1660100000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 14471510000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 14471510000.00
HCG.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2088700000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 8349900000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 8349900000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1394160000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1394160000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 2358710000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2358710000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2358750000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2358750000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 1066120000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 1066120000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1292590000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1292590000.00
HCG.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -96100000.00
HCG.NS cash_flow (annual, 2025-03-31) — Change In Payable: 295100000.00
HCG.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -1009000000.00
HCG.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -764600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -2130800000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1394160000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1394160000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 9224440000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 9224440000.00
HCG.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 15600000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 247560000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 247560000.00
HCG.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 10622700000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2832300000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Assets: 8437970000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 8437970000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 599040000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 599040000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Debt: 3976470000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 3976470000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4575510000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4575510000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 3190000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 3190000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 10464180000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 10464180000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 193500000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 193500000.00
HCG.NS cash_flow (annual, 2025-03-31) — Depreciation: 2113400000.00
HCG.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 2113400000.00
HCG.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 2113400000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 580700000.00
HCG.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 2113400000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 580700000.00
HCG.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 142339744.00
HCG.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 141538462.00
HCG.NS income_statement (annual, 2025-03-31) — Diluted EPS: 3.12
HCG.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.52
HCG.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 444100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 73600000.00
HCG.NS income_statement (annual, 2025-03-31) — EBIT: 2115200000.00
HCG.NS income_statement (quarterly, 2025-03-31) — EBIT: 577900000.00
HCG.NS income_statement (annual, 2025-03-31) — EBITDA: 4228600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1158600000.00
HCG.NS cash_flow (annual, 2025-03-31) — End Cash Position: -470700000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 70030000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 70030000.00
HCG.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -424400000.00
HCG.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 1082400000.00
HCG.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 10600000.00
HCG.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 601220000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Goodwill: 4299500000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 4299500000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 4954660000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 4954660000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 4816840000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 4816840000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 30599090000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 30599090000.00
HCG.NS income_statement (annual, 2025-03-31) — Gross Profit: 11558700000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 3002000000.00
HCG.NS income_statement (annual, 2025-03-31) — Interest Expense: 1545600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 441700000.00
HCG.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1545600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 441700000.00
HCG.NS income_statement (annual, 2025-03-31) — Interest Income: 158820000.00
HCG.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 158820000.00
HCG.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1581600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 94500000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Inventory: 530230000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 530230000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 19246750000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19246750000.00
HCG.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -4877500000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 277920000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 277920000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 43090000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 43090000.00
HCG.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 15600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 2220800000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1032270000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1032270000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 7750860000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 7750860000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 6045840000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 6045840000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13796700000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13796700000.00
HCG.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 2220800000.00
HCG.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -775600000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 43090000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 43090000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 214300000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 214300000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 13913040000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 13913040000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 676050000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 676050000.00
HCG.NS income_statement (annual, 2025-03-31) — Minority Interests: -44200000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 5900000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -1971900000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 15600000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Net Debt: 7663600000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 7663600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -800000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Income: 444100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Income: 73600000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 444100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 73600000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 488300000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 67700000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 444100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 73600000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 444100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 73600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 569600000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 488300000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 67700000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1545600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -441700000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -926800000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 1445200000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 1445200000.00
HCG.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1545600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -441700000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -42000000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Net PPE: 19712010000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 19712010000.00
HCG.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -2073300000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4269780000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4269780000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 387330000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 387330000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 249930000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 249930000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 35350000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 35350000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 214340000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 214340000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 901640000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 901640000.00
HCG.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 4228600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1158600000.00
HCG.NS income_statement (annual, 2025-03-31) — Normalized Income: 444100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 73600000.00
HCG.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 3171100000.00
HCG.NS income_statement (annual, 2025-03-31) — Operating Income: 1759400000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Operating Income: 476500000.00
HCG.NS income_statement (annual, 2025-03-31) — Operating Revenue: 22181400000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 5834300000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 140277065.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 140277065.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 345000000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 345000000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 367000000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 367000000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 223580000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 223580000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 655160000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 655160000.00
HCG.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 1301700000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -240000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -240000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -30000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -30000.00
HCG.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 348100000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 102300000.00
HCG.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 4198200000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1034000000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Payable: 257560000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 257560000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Properties: 934710000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 934710000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 7710000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 7710000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 40000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 40000.00
HCG.NS income_statement (annual, 2025-03-31) — Other Special Charges: 400000.00
HCG.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS balance_sheet (annual, 2025-03-31) — Payables: 3626520000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Payables: 3626520000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 193540000.00